467 related articles for article (PubMed ID: 3134894)
1. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
2. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
[TBL] [Abstract][Full Text] [Related]
3. Use of [3H]trimetoquinol as a radioligand in human platelets: interaction with putative endoperoxide/thromboxane A2 receptor sites.
Ahn CH; Wallace LJ; Miller DD; Feller DR
Thromb Res; 1988 May; 50(3):387-99. PubMed ID: 2969151
[TBL] [Abstract][Full Text] [Related]
4. Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta.
Romstedt KJ; Shin Y; Shams G; Doyle K; Tantishaiyakul V; Clark MT; Adejare A; Hamada A; Miller DD; Feller DR
Biochem Pharmacol; 1993 Dec; 46(11):2051-9. PubMed ID: 8267653
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo.
Shin Y; Romstedt KJ; Doyle K; Harrold MW; Gerhardt MA; Miller DD; Patil PN; Feller DR
Chirality; 1991; 3(2):112-7. PubMed ID: 1830752
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane antagonist properties of N-substituted trimetoquinol analogues.
Fedyna JS; Adejare A; Miller DD; Feller DR
Eur J Pharmacol; 1987 Mar; 135(2):161-71. PubMed ID: 2884118
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
8. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues.
Shams G; Romstedt KJ; Gerhardt MA; Harrold MW; Miller DD; Feller DR
Eur J Pharmacol; 1990 Aug; 184(1):21-31. PubMed ID: 1976530
[TBL] [Abstract][Full Text] [Related]
10. Stereo-dependent inhibition of human platelet function by the optical isomers of trimetoquinol.
Mayo JR; Navran SS; Huzoor-Akbar ; Miller DD; Feller DR
Biochem Pharmacol; 1981 Aug; 30(16):2237-41. PubMed ID: 7188564
[No Abstract] [Full Text] [Related]
11. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
de Chaffoy de Courcelles D; De Clerck F
Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
[TBL] [Abstract][Full Text] [Related]
12. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
Liel N; Mais DE; Halushka PV
J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and platelet antiaggregatory activity of trimetoquinol analogs as endoperoxide/thromboxane A2 antagonists.
Harrold MW; Gerhardt MA; Romstedt K; Feller DR; Miller DD
Drug Des Deliv; 1987 Feb; 1(3):193-207. PubMed ID: 3509333
[TBL] [Abstract][Full Text] [Related]
14. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
15. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells.
Shin Y; Romstedt KJ; Miller DD; Feller DR
J Pharmacol Exp Ther; 1993 Dec; 267(3):1017-23. PubMed ID: 7903383
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
17. Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function.
Swann PG; Parent CA; Croset M; Fonlupt P; Lagarde M; Venton DL; Le Breton GC
J Biol Chem; 1990 Dec; 265(35):21692-7. PubMed ID: 2147687
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
Bleasdale JE; Thakur NR; Gremban RS; Bundy GL; Fitzpatrick FA; Smith RJ; Bunting S
J Pharmacol Exp Ther; 1990 Nov; 255(2):756-68. PubMed ID: 2147038
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective inhibition of prostaglandin-induced calcium release from platelet membranes by trimetoquinol.
Mayo JR; Miller DD; Feller DR
Biochem Pharmacol; 1983 Jun; 32(12):1952-5. PubMed ID: 6882470
[No Abstract] [Full Text] [Related]
20. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]